Lupus anticoagulant, thrombosis, and death

In this issue of Blood, Gebhart et al report a prospective observational cohort study evaluating 151 patients with persistently positive lupus anticoagulant (LA) for a median period of 8.2 years. They observed increased mortality in LA-positive patients, mainly due to new thrombotic events.

Saved in:
Bibliographic Details
Published in:Blood 2015-05, Vol.125 (22), p.3371-3372
Main Author: Diz-Küçükkaya, Reyhan
Format: Article
Language:English
Subjects:
Antiphospholipid Syndrome - mortality
Female
Humans
Lupus Coagulation Inhibitor - blood
Male
Pregnancy
Thrombosis - mortality
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this issue of Blood, Gebhart et al report a prospective observational cohort study evaluating 151 patients with persistently positive lupus anticoagulant (LA) for a median period of 8.2 years. They observed increased mortality in LA-positive patients, mainly due to new thrombotic events.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2015-04-638320